Singapore markets closed

IDEAYA Biosciences, Inc. (IDYA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
37.04-0.67 (-1.78%)
As of 10:53AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
15,505
23,385
50,931
27,941
19,538
-
Operating expenses
Research development
144,454
129,508
89,536
58,158
39,698
-
Selling general and administrative
30,218
28,306
23,897
20,051
15,184
-
Total operating expenses
174,672
157,814
113,433
78,209
54,882
-
Operating income or loss
-159,167
-134,429
-62,502
-50,268
-35,344
-
Total other income/expenses net
-
-
-
-
-
8
Income before tax
-131,844
-112,961
-58,655
-49,762
-34,495
-
Income from continuing operations
-131,844
-112,961
-58,655
-49,762
-34,495
-
Net income
-131,844
-112,961
-58,655
-49,762
-34,495
-
Net income available to common shareholders
-131,844
-112,961
-58,655
-49,762
-34,495
-
Basic EPS
-1.98
-1.96
-1.42
-1.41
-1.40
-
Diluted EPS
-1.98
-1.96
-1.42
-1.41
-1.40
-
Basic average shares
53,238
57,520
41,445
35,252
24,722
-
Diluted average shares
53,238
57,520
41,445
35,252
24,722
-